Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain

Rizaldy C Zapata1, Olivia Osborn1

  • 1Division of Endocrinology and Metabolism, School of Medicine, University of California San Diego, La Jolla, CA 92093, United States.

Physiology & Behavior
|March 12, 2020
PubMed

Insights

Male Balb/c mice show significant weight gain with antipsychotic treatment, offering a better model for human side effects. This research is crucial for understanding long-term medication impacts on metabolism.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Obesity Research

Background:

  • Antipsychotic (AP) medications are associated with weight gain in both men and women.
  • Existing mouse models do not accurately reflect AP-induced weight gain observed in human males.

Purpose of the Study:

  • To identify a suitable strain of male mice for modeling AP-induced weight gain.
  • To investigate the potential of male mice to serve as a preclinical model for human AP treatment side effects.

Main Methods:

  • Administration of olanzapine to various strains of male mice.
  • Monitoring of body weight changes and other metabolic parameters over time.

Main Results:

  • Male Balb/c mice exhibited a significant, late-onset weight gain in response to olanzapine treatment.
  • This strain demonstrated susceptibility to AP-induced weight gain, unlike other tested male mouse strains.

Conclusions:

  • Male Balb/c mice represent a viable preclinical model for studying antipsychotic-induced weight gain.
  • Understanding these mechanisms is vital given the long-term use of APs in patients and their impact on weight regulation.

Related Concept Videos